Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Scorpio2on Dec 10, 2018 1:55pm
115 Views
Post# 29092741

RE:New CEO’s vs Financing

RE:New CEO’s vs FinancingI believe the new CEO to be hired will come from the new financial partner, thus they will already have knowledge of the financing arrangement that is to be announced shortly. So that addresses your issue of why would anyone accept the appointment without knowing the financing arrangements.

o me this would make infinite sense. If I was coughing up the money to TLT, I would certainly want "my man" in place from an oversight perspective to protect my investment.

As well, the fact that the position only pays $150,000 becomes a moot point if the person is also getting some degree of compensation from the financial partner in addition to what TLT will pay them. What TLT would pay them might also become irrelevant in a future pre-negotiated takeout arrangement subject to various conditions and milestones being achieved.
Bullboard Posts